China (Mainland)
Lorlatinib CAS NO.1454846-35-5
- FOB Price: USD: 130.00-150.00 /Gram Get Latest Price
- Min.Order: 10 Gram
- Payment Terms: L/C,T/T
- Available Specifications:
gram(10-100)Gramgram(100-500)Gram
- Product Details
Keywords
- Lorlatinib
- 99% purity
- in stock
Quick Details
- ProName: Lorlatinib
- CasNo: 1454846-35-5
- Molecular Formula: C21H19FN6O2
- Appearance: white to off-white crystalline powder
- Application: Lung cancer
- DeliveryTime: 3-4 weeks
- PackAge: double PE bags+Aluminum foil bags
- Port: Shenzhen
- ProductionCapacity: 5 Kilogram/Month
- Purity: 99%
- Storage: room temperature, dry place, keep from...
- Transportation: by air
- LimitNum: 10 Gram
- Related Substances: ≤1.0%
- Valid Period: two years
- Purity: ≥99.0%
Superiority
Topbatt Chemical Co., Ltd., Established in 2019, located in Shenzhen, Guangdong Province, is a Manufacturer and Trading company which specialized in fine chemicals like Pharmaceutical Reference Standards, Stable Isotopes, API and intermediates.
We own a number of Senior pharmaceutical synthetic engineer, analysis engineer and analytical testing instrument. It makes us have more than 1700 varieties compounds with high purity in stock in a short time.
We can provide you not only stock items, but also Custom Synthesis Service. All of our products provided with COA, HPLC/GC, NMR, MS Spectrum.
Contact us for more details, 24/7 stand by for you. After-sales issues will be settled in 24 hours.
Details
Product Name: Lorlatinib
Purity: 99%
Price: Negotiable
Lorlatinib is an anti-cancer drug developed by Pfizer. It is an orally administered inhibitor of ALK and ROS1, two enzymes that play a role in the development of cancer.
In 2015, FDA granted Pfizer orphan drug status for lorlatinib for the treatment of NSCLC. In 2018, the FDA approved lortalinib for second- or third-line treatment of ALK-positive metastatic NSCLC. In February 2019, the European CHMP of EMA recommended the granting of a conditional marketing authorisation. In May 2019 the European Commission approved lorlatinib for the 28 countries of the EU, also as a second- or third-line treatment.
We have been producing this API for about 3 years regularly and selling well all the time. We can offer package from 100g to 5kg or even bigger, it depends on clients.
Our manufacturing process has been developed very well and the cost is low, so our price is good and the quality is still good and stable.
